Innate Pharma S.A. (EPA:IPH)
1.776
-0.028 (-1.55%)
Apr 24, 2025, 10:42 AM CET
Innate Pharma Revenue
In the year 2024, Innate Pharma had annual revenue of 20.12M EUR, down -67.36%. Innate Pharma had revenue of 7.78M in the half year ending December 31, 2024, a decrease of -35.66%.
Revenue
20.12M
Revenue Growth
-67.36%
P/S Ratio
7.51
Revenue / Employee
111.17K
Employees
181
Market Cap
151.20M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 20.12M | -41.52M | -67.36% |
Dec 31, 2023 | 61.64M | 3.97M | 6.88% |
Dec 31, 2022 | 57.67M | 32.97M | 133.47% |
Dec 31, 2021 | 24.70M | -45.07M | -64.60% |
Dec 31, 2020 | 69.77M | -15.68M | -18.35% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
EssilorLuxottica Société anonyme | 26.51B |
Sanofi | 44.29B |
Sartorius Stedim Biotech | 2.86B |
bioMérieux | 3.98B |
Eurofins Scientific SE | 6.95B |
Ipsen | 3.57B |
Virbac | 1.40B |
emeis Société anonyme | 5.64B |
Innate Pharma News
- 1 day ago - Innate Pharma Regains Its Rights on CD123 Targeting ANKET® and Announces Sanofi's Intention to Make a Strategic Investment in the Company - Business Wire
- 8 days ago - Innate Pharma Proposes to Its Shareholders to Transform Its Corporate Governance Structure Into a Board of Directors and to Change Its Composition - Business Wire
- 8 days ago - Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 22, 2025 - Business Wire
- 21 days ago - Innate Pharma to Participate in the 2025 Stifel Virtual Targeted Oncology Forum - Business Wire
- 27 days ago - Innate Pharma S.A. (IPHA) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 27 days ago - Innate Pharma S.A. 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 27 days ago - Innate Pharma reports FY results - Seeking Alpha
- 4 weeks ago - Innate Pharma Reports Full Year 2024 Financial Results and Business Update - Business Wire